Literature DB >> 30692852

The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis.

Rahşan Göçmen1.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system and one of the leading causes of disability in young adults. While some patients with MS have a benign course in which they develop limited disability even after many years, other patients have a rapidly progressive course resulting in severe disability. However, the progression of the disease, particularly disability, is currently a predictable course with neuroimaging features to some extend. Magnetic resonance imaging (MRI) is not only the main diagnostic tool but also used to monitor response to therapies, thanks to its high sensitivity and ability to identify clinically silent lesions. This report presents a literature review which examines in detail the relationship between MRI findings and disability.

Entities:  

Keywords:  Multiple sclerosis; disability; magnetic resonance imaging; predictors

Year:  2018        PMID: 30692852      PMCID: PMC6278625          DOI: 10.29399/npa.23409

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  69 in total

Review 1.  T1 hypointensities and axonal loss.

Authors:  F Barkhof; G B Karas; M A van Walderveen
Journal:  Neuroimaging Clin N Am       Date:  2000-11       Impact factor: 2.264

Review 2.  The clinico-radiological paradox in multiple sclerosis revisited.

Authors:  Frederik Barkhof
Journal:  Curr Opin Neurol       Date:  2002-06       Impact factor: 5.710

3.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

4.  Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis.

Authors:  M Rovaris; M Bozzali; G Santuccio; G Iannucci; M P Sormani; B Colombo; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

5.  Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis.

Authors:  Marco Rovaris; Giancarlo Comi; David Ladkani; Jerry S Wolinsky; Massimo Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

6.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial.

Authors:  Roy W Beck; Jonathan D Trobe; Pamela S Moke; Robin L Gal; Dongyuan Xing; M Tariq Bhatti; Michael C Brodsky; Edward G Buckley; Georgia A Chrousos; James Corbett; Eric Eggenberger; James A Goodwin; Barrett Katz; David I Kaufman; John L Keltner; Mark J Kupersmith; Neil R Miller; Sarkis Nazarian; Silvia Orengo-Nania; Peter J Savino; William T Shults; Craig H Smith; Michael Wall
Journal:  Arch Ophthalmol       Date:  2003-07

7.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Authors:  Peter A Brex; Olga Ciccarelli; Jonathon I O'Riordan; Michael Sailer; Alan J Thompson; David H Miller
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

8.  Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability.

Authors:  J H van Waesberghe; W Kamphorst; C J De Groot; M A van Walderveen; J A Castelijns; R Ravid; G J Lycklama à Nijeholt; P van der Valk; C H Polman; A J Thompson; F Barkhof
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

9.  Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; G J M Parker; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-02       Impact factor: 13.501

10.  Multisequence MRI in clinically isolated syndromes and the early development of MS.

Authors:  P A Brex; J I O'Riordan; K A Miszkiel; I F Moseley; A J Thompson; G T Plant; D H Miller
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.